Wockhardt gets USFDA approval for antibiotic injection
DSIJ Intelligence / 07 Aug 2017
Wockhardt has received approval from the United States Foods & Drugs Administration (USFDA) for an ANDA for 1 gm, 2 gm injections of Oxacillin.
Wockhardt has received approval from the United States Foods & Drugs Administration (USFDA) for an ANDA for 1 gm, 2 gm injections of Oxacillin.
Oxacillin is a penicillinase-resistant, beta-lactam antibiotic and is used to treat many different infections caused by penicillinase-resistant Staphylococcal and other bacterial injections such as urinary tract infections, septicemia, wound infection, bacterial meningitis, etc. Wockhardt is expected to launch this product in the United States soon. The product is being manufactured at a contract manufacturing facility based near Milan, Italy.
On the financial front, Wockhardt’s consolidated revenue declined to Rs 891 crore in Q1FY18 on a YoY basis. It has reported net loss of Rs 463 crore in Q1FY18 versus net profit of Rs 15.9 crore in Q1FY17.
If you want to stay updated with the share market news today, keep a close watch on the indian stock market today with real time movements like sensex today live and overall stock market today trends. Investors tracking ipo allotment status, ipo news today, or the latest ipo india can also follow daily updates along with bse share price live data. Whether you are learning how to invest in stock market in india, preparing for a market crash today, or searching for the best stocks to buy in india, insights on top gainers today india, top losers today india, trending stocks india and long term stocks india help in making informed investment decisions.